Long‐Term Outcomes of Patients With Mediastinal Radiation–Associated Severe Aortic Stenosis and Subsequent Surgical Aortic Valve Replacement: A Matched Cohort Study

Background Cardiac disease after mediastinal radiotherapy for thoracic malignancy (chest radiotherapy [XRT]) often manifests as progressive aortic stenosis. In patients with XRT‐induced severe aortic stenosis undergoing surgical aortic valve replacement (SAVR), we sought to: (1) study long‐term survival and compare these patients with a matched cohort undergoing SAVR during the same time frame; and (2) identify potential predictors of long‐term mortality. Methods and Results We studied patients with symptomatic severe aortic stenosis undergoing SAVR at our institution, of which there were 172 mediastinal XRT patients (63±13 years, 62% women) matched in a 1:1 fashion (based on age, sex, time of surgery, and aortic valve area) with 172 non‐XRT patients (comparison group). Baseline clinical and postoperative data were obtained. Society of Thoracic Surgeons score was calculated and mortality was recorded. In the XRT group, the median Society of Thoracic Surgeons score was 4% (interquartile range 2–13), while mean left ventricular ejection fraction, left ventricular stroke volume index, and mean aortic valve gradient were 54±11%, 38±14 mL/m2, and 39±11 mm Hg, respectively. In the entire cohort, 27% and 34% of patients underwent concomitant coronary artery bypass grafting and aortic surgery at the time of SAVR, respectively. Thirty‐day/in‐hospital deaths occurred in 4 (2%) patients in the XRT group and 0 patients in the comparison group. At 6±3 years of follow‐up, on matched group analysis, there were 95 (28%) deaths (83 [48%] in the XRT group versus 12 [7%] in the comparison group (log‐rank 89, P<0.001). On multivariable Cox survival analysis, in the whole cohort, higher Society of Thoracic Surgeons score (hazard ratio, 1.14; 95% CI, 1.03–1.26) and mediastinal XRT (hazard ratio, 8.12; 95% CI, 4.26–15.64) were associated with increased longer‐term mortality (both P<0.01). Conclusions In patients with severe aortic stenosis undergoing SAVR, patients with prior mediastinal XRT have significantly worse longer‐term survival versus a matched cohort.

[1]  M. Desai,et al.  Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated With Percutaneous Coronary Intervention , 2016, Circulation. Cardiovascular interventions.

[2]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[3]  R. Biram,et al.  Association of the clinical frailty scale with hospital outcomes. , 2015, QJM : monthly journal of the Association of Physicians.

[4]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[5]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[6]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[7]  M. Desai,et al.  Outcomes of surgical aortic valve replacement for severe aortic stenosis: Incorporation of left ventricular systolic function and stroke volume index. , 2015, The Journal of thoracic and cardiovascular surgery.

[8]  N. Smedira,et al.  Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease. , 2015, Journal of Thoracic and Cardiovascular Surgery.

[9]  J. Raemaekers,et al.  Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. , 2015, JAMA internal medicine.

[10]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[11]  N. Smedira,et al.  Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. , 2014, The Journal of thoracic and cardiovascular surgery.

[12]  N. Smedira,et al.  Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. , 2014, The Annals of thoracic surgery.

[13]  N. Mousavi,et al.  Radiation-Induced Cardiovascular Disease , 2013, Current Treatment Options in Cardiovascular Medicine.

[14]  J. Mariani,et al.  Cardiac complications of thoracic irradiation. , 2013, Journal of the American College of Cardiology.

[15]  N. Smedira,et al.  Long-Term Survival of Patients With Radiation Heart Disease Undergoing Cardiac Surgery: A Cohort Study , 2013, Circulation.

[16]  P. Pibarot,et al.  Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[17]  R. Arriagada,et al.  Long-term cardiovascular mortality after radiotherapy for breast cancer. , 2011, Journal of the American College of Cardiology.

[18]  B. Carabello,et al.  Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment , 2009, European heart journal.

[19]  F. Neumann,et al.  Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. , 2008, European heart journal.

[20]  Richard D. White,et al.  Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. , 2008, The Annals of thoracic surgery.

[21]  B. Lytle,et al.  Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. , 2008, The Journal of thoracic and cardiovascular surgery.

[22]  Y. Takahara,et al.  Radiation-induced valvular disease is the logical consequence of irradiation , 2007, General thoracic and cardiovascular surgery.

[23]  N. Smedira,et al.  Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. , 2007, The Journal of thoracic and cardiovascular surgery.

[24]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[25]  C. Mullany,et al.  Valvular heart operation in patients with previous mediastinal radiation therapy. , 2001, The Annals of thoracic surgery.

[26]  E J Topol,et al.  Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.

[27]  C. Mullany,et al.  Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. , 1999, The Journal of thoracic and cardiovascular surgery.

[28]  M. Goldin,et al.  Surgical management of radiation-induced heart disease. , 1998, The Annals of thoracic surgery.

[29]  S L Hancock,et al.  Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.

[30]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[31]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.